Intelligent Insulin vs. Artificial Intelligence for Type 1 Diabetes: Will the Real Winner Please Stand Up?
Research in the treatment of type 1 diabetes has been addressed into two main areas: the development of “intelligent insulins” capable of auto-regulating their own levels according to glucose concentrations, or the exploitation of artificial intelligence (AI) and its learning capacity, to provide de...
Main Authors: | Valentina Maria Cambuli, Marco Giorgio Baroni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/17/13139 |
Similar Items
-
Synthesis and Characterization of Phenylboronic Acid-Modified Insulin With Glucose-Dependent Solubility
by: Nai-Pin Lin, et al.
Published: (2022-03-01) -
Derangements of liver tissue bioenergetics in Concanavalin A-induced hepatitis
by: Al-Shamsi Mariam, et al.
Published: (2013-01-01) -
A Closed Loop Stimuli-Responsive Concanavalin A-Loaded Chitosan–Pluronic Hydrogel for Glucose-Responsive Delivery of Short-Acting Insulin Prototyped in RIN-5F Pancreatic Cells
by: Shazia Mansoor, et al.
Published: (2023-09-01) -
A Porous Reservoir-Backed Boronate Gel Microneedle for Efficient Skin Penetration and Sustained Glucose-Responsive Insulin Delivery
by: Siyuan Chen, et al.
Published: (2022-01-01) -
Biochemical, Thermodynamic and Kinetic Characterization of Glucose Oxidase Purified from Pseudomonas and Actinomyces spp. from Natural Sources
by: Sujeet Pratap Singh, et al.
Published: (2019-12-01)